LWM
VSTM icon

Laidlaw Wealth Management’s Verastem VSTM Stock Holding History

Laidlaw Wealth Management’s Portfolio VSTM Stock Details VSTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,983
Closed -$82K – 215
2020
Q2 		$82K Buy
+3,983
New +$105K 0.04% 177

Other funds holding VSTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Laidlaw Wealth Management's VSTM Position: Q3 2020 in Review

Laidlaw Wealth Management sold out of Verastem (VSTM) in Q3 2020, closing a stake of 3,983 shares — an estimated $82K sold.

Laidlaw Wealth Management first reported a position in VSTM in Q2 2020 and held it in 1 quarter. The position peaked at $82K in Q2 2020. 122 funds tracked by Wall St. Rank hold VSTM as of Q3 2020.

  • Laidlaw Wealth Management reported no remaining Verastem position as of Q3 2020 after selling out during the quarter.
  • Laidlaw Wealth Management sold 3,983 Verastem shares in Q3 2020, an estimated $82K.
  • Laidlaw Wealth Management first reported a position in Verastem in Q2 2020 and held it in 1 quarter.
  • Laidlaw Wealth Management's Verastem position peaked at $82K in Q2 2020.
  • 122 funds tracked by Wall St. Rank held Verastem as of Q3 2020.

Based on Laidlaw Wealth Management's 13F filing for Q3 2020, filed 16 Nov 2020.